Live practitioner training · Thursday 17 September 2026
Your clients are starting GLP-1s. The gut symptoms land with you.
GLP-1 agonists, the microbiome and SIBO: a clinical framework for supporting the gut before, during and after treatment. The mechanism that makes semaglutide and tirzepatide effective is the same one that predisposes to small intestinal overgrowth.
Live online · A$111, one payment
Register for A$111Register before the session starts on Thursday 17 September to join live and bring a case to the Q&A. Can't attend? The recording goes into your portal afterwards and it's yours to keep.
The clinical problem
Prescribing has moved faster than the gut advice
GLP-1 receptor agonists slow gastric emptying and small intestinal transit. That slowing is a large part of how they produce satiety and glycaemic control, so the gut consequences come from the same mechanism as the benefit. It is also why they rarely settle on their own.
Your clients are not taking bloating and early fullness back to the prescriber. They are bringing it to you. And "your medication is doing that", however true, is not a plan.
Stasis is the precondition small intestinal overgrowth needs. A client on months of slowed transit, falling fibre intake and shrinking dietary variety is a client whose microbiome is being reshaped while nobody is watching it.
What you're already seeing
- Constipation that starts within weeks of the first dose
- Bloating and early fullness on a fraction of previous intake
- Nausea and reflux written off as "the medication settling in"
- Protein and fibre falling away as appetite disappears
- The client who tests positive months in, with no other obvious trigger
To be clear about scope: starting, adjusting or stopping a GLP-1 is the prescriber's decision. Your work is the gut alongside it.
The curriculum
What you'll cover
Four segments, taught in the order you would use them in practice.
1 · The medications & the biology
What GLP-1 receptor agonists do to appetite, gastric emptying, transit and glycaemic control, and where endogenous GLP-1 and short-chain fatty acids sit in the same pathway.
2 · Before treatment starts
The pre-treatment work-up: what to screen for, why constipation gets resolved first, how to build fibre and diversity while appetite is still intact, the therapies worth having in place, and nausea support.
3 · The SIBO risk
Why the mechanism that makes these drugs effective is the same one that predisposes to overgrowth. What to monitor, when testing is worth it, and how to support motility through treatment rather than cleaning up afterwards.
4 · Guest segment & live Q&A
Carla Wrenn on her personal and clinical experience with GLP-1 therapy, then open Q&A. Bring the cases you are stuck on.
The outcome
What you'll walk away with
Something you can use in Monday's consult.
A protocol, not a supplement list
The pre-treatment sequence: what happens first, what waits, and what you check before your client's first dose.
Language for the conversation
How to talk about GI symptoms with a client who is not stopping their medication, and how to work alongside the prescriber rather than around them.
A motility-first plan for the months after
What to monitor through treatment, when to test, and where the SIBO Restore Diet™ fits if overgrowth is confirmed.
One session. A framework you'll use with every client on a GLP-1.
Thursday 17 September 2026 · Live online · Recording included
Register for A$111Your presenters
Who's teaching
Karly Raven, BHSc
Naturopath · SIBO and microbiome · practitioner educator
Karly is the founder of the Nourished Gut Clinic and the creator of the SIBO Restore Diet™ and the Feed Forward Method™. She works exclusively in complex gut cases and trains practitioners in dietary restoration for SIBO and chronic gut conditions. Member, NHAA.
Carla Wrenn
Guest expert
Carla joins Karly for the guest segment to share her personal and clinical experience with GLP-1 therapy: what she saw in her own body, and what she now watches for in her clients.
Logistics
The details
Date
Thursday 17 September 2026. Your joining link and calendar invite are emailed in the days before the session.
Format
Live online. Teaching first, then the guest segment with Carla, then open Q&A.
Access
The recording is added to your portal after the session and stays there. Register even if you can't attend live.
Price
A$111, one payment. Practitioner-level clinical content.
Before you register
Questions practitioners ask
I can't attend live. Is it still worth registering?
Who is this for?
Do I need the SIBO Restore Dietā„¢ Practitioner Training first?
Is this about taking clients off their medication?
None of my clients are on a GLP-1 yet.
What happens after I register?
Thursday 17 September 2026
Save your spot
Live online. Register before the session starts to join live and bring a case to the Q&A. A$111, one payment.
Register for A$111Questions before you register? Email [email protected] · Terms & conditions
